Company / Accounts Receivable
Xencor Inc Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$29.3M
FY2025
5-year range
$23.7M / $66.4M
FY2021-FY2025
Trend
-51.8%
vs FY2024
Sector context
#83 of 113
Health Care
What the data says
At $29M, Xencor Inc's accounts receivable ranks #83 of 113 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $1M in FY2017 to $66M in FY2021.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of +20.7%.
Improved from $24M to $29M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- +20.7%
- 10-Year CAGR
- -
Sector benchmark
#83 of 113 in Health CareTop 73% of 113This company $29.3M Sector average $1.1B
▼
-97.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.7%, indicating consistent growth.
- In FY2025, accounts receivable decreased 51.8% year-over-year.
- Ranks #83 out of 113 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.3M | -51.8% |
| FY2024 | $60.8M | +156.3% |
| FY2023 | $23.7M | -18.1% |
| FY2022 | $29.0M | -56.3% |
| FY2021 | $66.4M | +480.1% |
| FY2020 | $11.4M | -47.0% |
| FY2019 | $21.6M | +111.8% |
| FY2018 | $10.2M | +792.0% |
| FY2017 | $1.1M | -86.7% |
| FY2016 | $8.6M | +19481.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026